Island Kinetics, Inc. D.B.A. CoValence Laboratories FDA Record

Warning letters, Form 483s, inspections, recalls and 510(k) clearances

  • Latest inspection OAI · Jan 23, 2026
  • Last warning letter 2026
Inspections 6 1 OAI
Recalls 5 0 Class I (0%)
Warning letters 1 Latest Jul 16, 2026
510(k) clearances 0 None on file

Island Kinetics, Inc. D.B.A. CoValence Laboratories has 5 FDA recalls, 6 inspections, 0 510(k) clearances and 1 compliance action on record. FDA has issued 1 warning letter to Island Kinetics, Inc. D.B.A. CoValence Laboratories, the most recent on Jul 16, 2026.

What these totals cover: FDA records filed under the name "Island Kinetics, Inc. D.B.A. CoValence Laboratories".

Latest recall
D-0487-2026 · Class II · Apr 1, 2026
Latest inspection
Jan 23, 2026 · OAI

Summary

Record counts and when each FDA source was last refreshed
RecordsCountLast refreshedSource as ofStatus
Recalls5Nov 11, 2026 (checked Nov 15, 2026, unchanged)File dated Nov 10, 2026Current
510(k) clearances0Nov 15, 2026File dated Nov 9, 2026Current
Inspections6Nov 16, 2026Newest record Nov 5, 2026Current
Compliance actions1Nov 2, 2026Newest record Oct 29, 2026Current

FDA record by year

Island Kinetics, Inc. D.B.A. CoValence Laboratories's FDA inspections, warning letters and recalls in each of the last 10 calendar years (2017 to 2026, 2026 so far).

Island Kinetics, Inc. D.B.A. CoValence Laboratories: FDA inspections per year

2017: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2018: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2019: 0 inspections (0 OAI), 0 warning letters, 1 recall record (0 Class I) 2020: 1 inspection (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2021: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2022: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2023: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2024: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2025: 0 inspections (0 OAI), 0 warning letters, 0 recall records (0 Class I) 2026: 1 inspection (1 OAI), 1 warning letter, 4 recall records (0 Class I)
YearInspectionsOAIWarning lettersRecall recordsClass I
202611140
202500000
202400000
202300000
202200000
202100000
202010000
201900010
201800000
201700000

Inspections are counted by the date they ended, warning letters by the date FDA issued them and recall records by the recall start date. FDA lists one recall record per recalled product, so one recall event can add several.

Reviewing Island Kinetics, Inc. D.B.A. CoValence Laboratories as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Island Kinetics, Inc. D.B.A. CoValence Laboratories yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Island Kinetics, Inc. D.B.A. CoValence Laboratories FDA Warning Letters

1 warning letter on Jul 16, 2026.

IssuedSubjectIssuing officeClose-out letter
Jul 16, 2026 · Letter on fda.gov CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/AdulteratedCenter for Drug Evaluation and Research (CDER)

A warning letter is FDA's formal notice that a company has violated FDA requirements. Each date links to the letter on fda.gov where FDA has it online. Search the text of every letter with the FDA warning letter search.

Recent recalls

5 recall records from Dec 20, 2019 to Apr 1, 2026.

NumberClassProductDate
D-0487-2026Class IIBlemish Spot Treatment (Salicylic Acid) 1%, .5 fl oz (15 ml) bottles, Skin Script, Chandler, AZ…Apr 1, 2026
D-0480-2026Class IIIRemedy Gel, hydrocortisone 1%, 30 mL/ 1 fl oz per bottle, Distributed By: glo Skin Beauty, Denver…Mar 18, 2026
D-0482-2026Class IIIEssential Calming Skin Gel, hydrocortisone 1%, 120mL/4oz net wt. (113g) per jar, Distributed By…Mar 18, 2026
D-0481-2026Class IIISkin Rehab, Calming Skin Gel, Hydrocortisone Balm, hydrocortisone 1%, .53oz net wt. (15.3g) per…Mar 18, 2026
D-0634-2020Class IIIPCA Skin Blemish Control Bar, 3.2 oz/90g, Salicylic acid 2% - Acne cleanser, For external use only…Dec 20, 2019

Recent FDA inspections

6 inspections from Jun 16, 2010 to Jan 23, 2026.

DateSiteProductClassificationFEI
Jan 23, 2026Chandler, AZDrugsOfficial Action Indicated (OAI)3002408934
Jan 6, 2020Chandler, AZDrugsVoluntary Action Indicated (VAI)3002408934
Sep 2, 2016Chandler, AZDrugsVoluntary Action Indicated (VAI)3002408934
May 16, 2012Chandler, AZDrugsNo Action Indicated (NAI)3002408934
Apr 21, 2011Chandler, AZDrugsNo Action Indicated (NAI)3002408934
Jun 16, 2010Chandler, AZDrugsNo Action Indicated (NAI)3002408934
NAI
No objectionable conditions or practices were found during the inspection.
VAI
Objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action.
OAI
Regulatory and/or administrative actions are recommended.

Look up the inspector observations behind these results with the FDA 483 search, or check for formal enforcement with the FDA warning letter search.

Compliance Actions

FDA's compliance actions data lists 1 compliance action under Island Kinetics, Inc. D.B.A. CoValence Laboratories: warning letters, injunctions and seizures. None came from FDA's Center for Tobacco Products.

Most recent: Warning Letter, Jul 16, 2026.

The warning letters in this data are listed above, together with the letters FDA posts online; a letter found in both is shown once. Other actions are not listed on this page. Search them with the FDA warning letter search or browse all compliance actions.

FDA-inspected facilities

1 inspected site, newest inspection first.

FacilityLocationInspectionsLatest
FEI 3002408934Chandler, AZ6Jan 23, 2026

Island Kinetics, Inc. D.B.A. CoValence Laboratories and the FDA: common questions

Has Island Kinetics, Inc. D.B.A. CoValence Laboratories received an FDA warning letter?

Yes. FDA has issued 1 warning letter to Island Kinetics, Inc. D.B.A. CoValence Laboratories. The most recent is dated Jul 16, 2026, with the subject "CGMP/Finished Pharmaceuticals/Unapproved New Drug/Misbranded/Adulterated".

Has Island Kinetics, Inc. D.B.A. CoValence Laboratories received an FDA Form 483?

FDA has not published a Form 483 for "Island Kinetics, Inc. D.B.A. CoValence Laboratories" in its reading room. FDA publishes some Form 483s, not all of them.

When did the FDA last inspect Island Kinetics, Inc. D.B.A. CoValence Laboratories?

The most recent FDA inspection on file ended Jan 23, 2026 at Chandler, AZ and was classified OAI. FDA has 6 inspections of Island Kinetics, Inc. D.B.A. CoValence Laboratories on file, 1 of them classified OAI (official action indicated).

Has Island Kinetics, Inc. D.B.A. CoValence Laboratories had an FDA recall?

Yes. Island Kinetics, Inc. D.B.A. CoValence Laboratories has 5 FDA recalls on record. The most recent started Apr 1, 2026.

Need more than this page shows? Ask about Island Kinetics, Inc. D.B.A. CoValence Laboratories in Claude or ChatGPT and get every site's inspections, Form 483s, warning letters and import alerts, with a link to the FDA source for each record. The API key is free: no card.

Get a free API key

Prefer a PDF? Request a free supplier snapshot.

Is this your company or a supplier you list? Link to this FDA record from your site with a free button.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.